From 2027 onward, eDiLO only: what patients and healthcare providers need to know about oncology cards
From the beginning of 2027, the DiLO card will exist only in electronic form. A patient without an active DiLO or eDiLO card will not receive NFZ funding for diagnostics or planned treatment of malignant neoplasms.

Vitaly Gariev · Unsplash License
- 0views
- 0likes and saves
- 0skips
In brief
- From 1 January 2027, the oncology card will be issued only in electronic form as eDiLO.
- The National Health Fund (NFZ) will finance diagnostics and planned treatment of malignant neoplasms only for patients with an active DiLO or eDiLO card.
- Previously issued cards will retain their validity, and people undergoing treatment may continue using them.
- Data from eDiLO are to be used to assess centres according to the indicators of the National Oncology Network (Krajowa Sieć Onkologiczna).
End of the paper oncology card
From 1 January 2027, the card for oncology diagnostics and treatment will be issued only electronically, as eDiLO (Wchodzi eDiLO. Od 1 stycznia ważne zmiany dla pacjentów onkologicznych – zwrotnikraka.pl) (Komunikat dot. realizacji diagnostyki i leczenia nowotworów po 1 stycznia 2027 r. w oparciu o kartę DiLO – NFZ – Zachodniopomorski Oddział Wojewódzki). The Ministry of Health reminds that from this date the National Health Fund will pay for tests and planned treatment of malignant neoplasms only for people with an active DiLO or eDiLO card. The ministry's announcement of 27 October applies both to people who will only now seek help and to patients remaining under the care of oncologists (Zmiany w leczeniu raka od 2027 roku. Co z pacjentami, którzy już mają kartę DiLO? – GazetaPrawna.pl).
Cards issued earlier
People undergoing diagnostics or therapy may continue treatment with their existing card.
Where to check the card and who can access it
You can already check the electronic card in the Internetowe Konto Pacjenta (Internet Patient Account) and in the mojeIKP application. A card issued in a hospital is visible to the patient's primary health care (POZ) physician (Karta e-DILO – pytania i odpowiedzi – ezdrowie.gov.pl (CEZ)). A POZ physician who issued the card themselves can monitor its progress at subsequent stages. If they did not issue it, they will gain access to it provided the patient has filed a declaration with them.
Data from eDiLO and the assessment of centres
Data collected in eDiLO are to form the basis for assessing centres according to the quality indicators of the National Oncology Network (Krajowa Sieć Onkologiczna). The Ministry plans to develop these indicators by the end of 2026. A facility that does not meet key indicators may be removed from the network.
What facilities are doing
The ministry encourages facilities to prepare in advance for the changes technically, organisationally and substantively. The goal is continuity of diagnostics and treatment for patients and continuity of financing for facilities.
What to check before a visit
A patient may ask their facility or POZ physician whether their card is active and who has access to it.
Read also
- Karta DiLO – etapowe przejście na wersję elektroniczną do końca 2026 roku
Sources
- [1]Karta e-DILO – pytania i odpowiedzi· ezdrowie.gov.pl (CEZ)
- [2]Komunikat dot. realizacji diagnostyki i leczenia nowotworów po 1 stycznia 2027 r. w oparciu o kartę DiLO· NFZ – Zachodniopomorski Oddział Wojewódzki
- [3]
Zmiany w leczeniu raka od 2027 roku. Co z pacjentami, którzy już mają kartę DiLO?· GazetaPrawna.pl
- [4]Wchodzi eDiLO. Od 1 stycznia ważne zmiany dla pacjentów onkologicznych· zwrotnikraka.pl
Discussion0
- No comments from this perspective yet. Be the first.